Preview Mode Links will not work in preview mode

Clinical Summaries presented by InpharmD™

Sep 26, 2020

What does the evidence say on the safety and immunogenicity of the new Novavax vaccine for the SARS-CoV-2 infection?


Sep 17, 2020

Is cell phone location data associated with the rate of change in new COVID-19 cases by county across the US? Tune in to what the evidence say.


Sep 11, 2020

An open-label, non-randomized, single-arm, Expanded Access Program (EAP) trial conducted to explore potential signals of efficacy of COVID-19 convalescent plasma.

Read more here: inpharmd.com/covid 


Sep 2, 2020

A prospective, multi-center, single-blind, randomized controlled phase II trial assessing the efficacy and safety of ruxolitinib in hospitalized COVID-19 patients